You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 154 No. 12, December 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Article
 This Article
 •Full text
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (23)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Drug Therapy
 •Alert me on articles by topic

Treatment of Sialorrhea With Glycopyrrolate

A Double-blind, Dose-Ranging Study

Richard J. Mier, MD; Steven J. Bachrach, MD; Ryan C. Lakin, MS; Tara Barker, BS; Judith Childs, PhD; Maria Moran, MS

Arch Pediatr Adolesc Med. 2000;154:1214-1218.

Objective  To determine the safety and efficacy of glycopyrrolate in the treatment of developmentally disabled children with sialorrhea.

Design  Placebo-controlled, double-blind, crossover dose-ranging study.

Setting  Outpatient facilities in 2 pediatric hospitals.

Patients  Thirty-nine children with both developmental disabilities and excessive and bothersome sialorrhea.

Main Outcome Measures  Parent and investigator evaluation of change in sialorrhea and adverse effects.

Results  Glycopyrrolate in doses of 0.10 mg/kg per dose is effective at controlling sialorrhea. Even at low doses, 20% of children may exhibit adverse effects severe enough to require discontinuation.

Conclusions  Glycopyrrolate is effective in the control of excessive sialorrhea in children with developmental disabilities. Approximately 20% of children given glycopyrrolate may experience substantial adverse effects, enough to require discontinuation of medication.


From the Shriners Hospital for Children, Lexington, Ky (Dr Mier, Mr Lakin, and Ms Barker), and the Alfred I. duPont Hospital for Children, Wilmington, Del (Drs Bachrach and Childs and Ms Moran).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Advances in the diagnosis and management of chronic pulmonary aspiration in children
Boesch et al.
Eur Respir J 2006;28:847-861.
ABSTRACT | FULL TEXT  

Effect of Botulinum Toxin in the Treatment of Drooling: A Controlled Clinical Trial
Jongerius et al.
Pediatrics 2004;114:620-627.
ABSTRACT | FULL TEXT  

A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling
Jongerius et al.
Arch. Dis. Child. 2003;88:911-914.
ABSTRACT | FULL TEXT  

Anticholinergics
Journal of the American Dental Association 2001;132:1021-1022.
FULL TEXT  

Treatment for Drooling
JWatch Psychiatry 2001;2001:13-13.
FULL TEXT  

Treatment for Drooling
JWatch General 2000;2000:8-8.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.